Equity Overview
Price & Market Data
Price: $0.0768
Daily Change: -$0.0082 / 10.68%
Daily Range: $0.071 - $0.0876
Market Cap: $14,412,225
Daily Volume: 75,670
Performance Metrics
1 Week: -10.29%
1 Month: -7.47%
3 Months: -18.56%
6 Months: -0.14%
1 Year: -26.79%
YTD: -20.50%
Details
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. It also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.